144 related articles for article (PubMed ID: 37824087)
21. Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages.
Zhang Y; Chen Y; Li J; Zhu X; Liu Y; Wang X; Wang H; Yao Y; Gao Y; Chen Z
ACS Appl Mater Interfaces; 2021 Jun; 13(21):24442-24452. PubMed ID: 34008947
[TBL] [Abstract][Full Text] [Related]
22. Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy.
Li SL; Hou HY; Chu X; Zhu YY; Zhang YJ; Duan MD; Liu J; Liu Y
ACS Nano; 2024 Mar; 18(11):7769-7795. PubMed ID: 38420949
[TBL] [Abstract][Full Text] [Related]
23. Adoptive transfer of Fe
Zhang Y; Liu S; Li D; He C; Wang D; Wei M; Zheng S; Li J
Colloids Surf B Biointerfaces; 2023 Sep; 229():113452. PubMed ID: 37474429
[TBL] [Abstract][Full Text] [Related]
24. Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth.
Ramesh A; Malik V; Brouillard A; Kulkarni A
J Biomed Mater Res A; 2022 Aug; 110(8):1448-1459. PubMed ID: 35388955
[TBL] [Abstract][Full Text] [Related]
25. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
[TBL] [Abstract][Full Text] [Related]
26. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
27. Dual source-powered multifunctional Pt/FePc@Mn-MOF spindle-like Janus nanomotors for active CT imaging-guided synergistic photothermal/chemodynamic therapy.
Zhang X; Liu C; Li J; Chu R; Lyu Y; Lan Z
J Colloid Interface Sci; 2024 Mar; 657():799-810. PubMed ID: 38081114
[TBL] [Abstract][Full Text] [Related]
28. The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.
Zhang C; Wei S; Dai S; Li X; Wang H; Zhang H; Sun G; Shan B; Zhao L
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217247
[TBL] [Abstract][Full Text] [Related]
29. M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects.
Xiao H; Guo Y; Li B; Li X; Wang Y; Han S; Cheng D; Shuai X
ACS Cent Sci; 2020 Jul; 6(7):1208-1222. PubMed ID: 32724855
[TBL] [Abstract][Full Text] [Related]
30. Dual Inhibition of Endoplasmic Reticulum Stress and Oxidation Stress Manipulates the Polarization of Macrophages under Hypoxia to Sensitize Immunotherapy.
Jiang M; Li X; Zhang J; Lu Y; Shi Y; Zhu C; Liu Y; Qin B; Luo Z; Du Y; Luo L; Peng L; You J
ACS Nano; 2021 Sep; 15(9):14522-14534. PubMed ID: 34414762
[TBL] [Abstract][Full Text] [Related]
31. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
[TBL] [Abstract][Full Text] [Related]
32. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy.
Zhang W; Liu X; Cao S; Zhang Q; Chen X; Luo W; Tan J; Xu X; Tian J; Saw PE; Luo B
ACS Nano; 2023 Aug; 17(15):14424-14441. PubMed ID: 37498878
[TBL] [Abstract][Full Text] [Related]
34. M2pep-Modified Cyclodextrin-siRNA Nanoparticles Modulate the Immunosuppressive Tumor Microenvironment for Prostate Cancer Therapy.
Sun Y; Cronin MF; Mendonça MCP; Guo J; O'Driscoll CM
Mol Pharm; 2023 Nov; 20(11):5921-5936. PubMed ID: 37874541
[TBL] [Abstract][Full Text] [Related]
35. Targeting tumor associated macrophages (TAMs) via nanocarriers.
Singh Y; Pawar VK; Meher JG; Raval K; Kumar A; Shrivastava R; Bhadauria S; Chourasia MK
J Control Release; 2017 May; 254():92-106. PubMed ID: 28377038
[TBL] [Abstract][Full Text] [Related]
36. Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer.
Chen S; He Y; Huang X; Shen Y; Zou Q; Yang G; Fu L; Liu Q; Luo D
J Nanobiotechnology; 2024 Jun; 22(1):348. PubMed ID: 38898486
[TBL] [Abstract][Full Text] [Related]
37. Hybrid Cellular Nanovesicles Block PD-L1 Signal and Repolarize M2 Macrophages for Cancer Immunotherapy.
Zhao C; Pan Y; Liu L; Zhang J; Wu X; Liu Y; Zhao XZ; Rao L
Small; 2024 Mar; ():e2311702. PubMed ID: 38456371
[TBL] [Abstract][Full Text] [Related]
38. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.
Ye J; Yang Y; Dong W; Gao Y; Meng Y; Wang H; Li L; Jin J; Ji M; Xia X; Chen X; Jin Y; Liu Y
Int J Nanomedicine; 2019; 14():3203-3220. PubMed ID: 31118632
[No Abstract] [Full Text] [Related]
39. In situ Engineering of Tumor-Associated Macrophages via a Nanodrug-Delivering-Drug (β-Elemene@Stanene) Strategy for Enhanced Cancer Chemo-Immunotherapy.
Chen W; Li Y; Liu C; Kang Y; Qin D; Chen S; Zhou J; Liu HJ; Ferdows BE; Patel DN; Huang X; Koo S; Kong N; Ji X; Cao Y; Tao W; Xie T
Angew Chem Int Ed Engl; 2023 Oct; 62(41):e202308413. PubMed ID: 37380606
[TBL] [Abstract][Full Text] [Related]
40. Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy.
Chen M; Shen Y; Pu Y; Zhou B; Bing J; Ge M; Zhu Y; Gao S; Wu W; Zhou M; Shi J
Biomaterials; 2023 Dec; 303():122386. PubMed ID: 37977008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
